Days spent at home in the last 6 months of life: a quality indicator of end of life care in patients with hematologic malignancies.
Hematologic malignancies
days at home
end of life
health services research
palliative care
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
pubmed:
23
8
2019
medline:
28
4
2021
entrez:
23
8
2019
Statut:
ppublish
Résumé
Despite advances in the management of hematologic malignancies, a significant proportion of patients die of their disease. We used administrative databases in Ontario, Canada (between 2005 and 2013) to determine the number of days spent at home in the last 6 months of life. We studied the predictors of the median number of days at home (DAH) using quantile regression. For the 11,127 patients with hematologic malignancies who died, the median number of DAH in the last 6 months was 156 days. Patients with acute leukemias (
Identifiants
pubmed: 31437075
doi: 10.1080/10428194.2019.1654095
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM